Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024
Intelligent Bio Solutions Inc. (Nasdaq: INBS), a pioneer in non-invasive drug testing technology, has announced its participation in the upcoming Sidoti Small-Cap Virtual Conference scheduled for September 18-19, 2024. The company's management team is set to present on Thursday, September 19, 2024, at 2:30 p.m. Eastern Time.
Interested parties can register for the webcast through the provided Zoom link. For those seeking additional information about the conference or wishing to arrange one-on-one meetings with INBS management, contacting a Sidoti representative or reaching out to KCSA Strategic Communications via email at INBS@ksca.com is recommended.
This participation underscores INBS's commitment to engaging with investors and showcasing its innovative solutions in the biotechnology sector.
Intelligent Bio Solutions Inc. (Nasdaq: INBS), un pioniere nella tecnologia di test farmacologici non invasivi, ha annunciato la sua partecipazione alla prossima Sidoti Small-Cap Virtual Conference programmata per 18-19 settembre 2024. Il team di gestione dell'azienda presenterà giovedì 19 settembre 2024, alle 14:30 ora orientale.
Le parti interessate possono registrarsi per il webcast tramite il link Zoom fornito. Per chi desidera ulteriori informazioni sulla conferenza o desidera organizzare incontri individuali con il management di INBS, si consiglia di contattare un rappresentante di Sidoti o di contattare KCSA Strategic Communications via email all'indirizzo INBS@ksca.com.
Questa partecipazione sottolinea l'impegno di INBS nel coinvolgere gli investitori e nel presentare le sue soluzioni innovative nel settore biotecnologico.
Intelligent Bio Solutions Inc. (Nasdaq: INBS), un pionero en la tecnología de pruebas de drogas no invasivas, ha anunciado su participación en la próxima Sidoti Small-Cap Virtual Conference programada para 18-19 de septiembre de 2024. El equipo directivo de la empresa presentará el jueves 19 de septiembre de 2024, a las 2:30 p.m. hora del este.
Las partes interesadas pueden registrarse para la transmisión web a través del enlace de Zoom proporcionado. Para aquellos que busquen información adicional sobre la conferencia o deseen organizar reuniones uno a uno con la dirección de INBS, se recomienda contactar a un representante de Sidoti o comunicarse con KCSA Strategic Communications por correo electrónico a INBS@ksca.com.
Esta participación subraya el compromiso de INBS con el compromiso de los inversionistas y la presentación de sus soluciones innovadoras en el sector de biotecnología.
인텔리전트 바이오 솔루션즈 주식회사 (Nasdaq: INBS), 비침습적인 약물 테스트 기술의 선구자로, 다가오는 시도티 소형주 가상 컨퍼런스에 참여한다고 발표했습니다. 이 회의는 2024년 9월 18-19일에 예정되어 있습니다. 회사의 경영진은 2024년 9월 19일 목요일, 동부 표준시 오후 2시 30분에 발표할 예정입니다.
관심 있는 사람은 제공된 Zoom 링크를 통해 웹캐스트에 등록할 수 있습니다. 컨퍼런스에 대한 추가 정보를 원하거나 INBS 경영진과 일대일 회의를 주선하고자 하는 경우, 시도티 대표자에게 연락하거나 KCSA 전략 커뮤니케이션에 INBS@ksca.com으로 이메일을 보내는 것이 좋습니다.
이번 참여는 INBS가 투자자와의 소통에 헌신하고 생명공학 분야에서 혁신적인 솔루션을 선보이기 위한 노력을 강조합니다.
Intelligent Bio Solutions Inc. (Nasdaq: INBS), un pionnier dans la technologie de dépistage non invasif des drogues, a annoncé sa participation à la prochaine Sidoti Small-Cap Virtual Conference prévue pour les 18 et 19 septembre 2024. L'équipe de direction de l'entreprise présentera le jeudi 19 septembre 2024, à 14h30, heure de l'Est.
Les parties intéressées peuvent s'inscrire au webinaire via le lien Zoom fourni. Pour ceux qui souhaitent obtenir des informations supplémentaires sur la conférence ou organiser des réunions individuelles avec la direction d'INBS, il est recommandé de contacter un représentant de Sidoti ou de joindre KCSA Strategic Communications par email à INBS@ksca.com.
Cette participation souligne l'engagement d'INBS à dialoguer avec les investisseurs et à présenter ses solutions innovantes dans le secteur de la biotechnologie.
Intelligent Bio Solutions Inc. (Nasdaq: INBS), ein Pionier in der nicht-invasiven Drogen-Testtechnologie, hat seine Teilnahme an der bevorstehenden Sidoti Small-Cap Virtual Conference angekündigt, die für 18-19 September 2024 geplant ist. Das Managementteam des Unternehmens wird am Donnerstag, den 19. September 2024, um 14:30 Uhr Eastern Time präsentieren.
Interessierte Parteien können sich über den bereitgestellten Zoom-Link für das Webcast registrieren. Für diejenigen, die zusätzliche Informationen zur Konferenz suchen oder Einzelgespräche mit dem INBS-Management arrangieren möchten, wird empfohlen, einen Sidoti-Vertreter zu kontaktieren oder KCSA Strategic Communications per E-Mail unter INBS@ksca.com zu erreichen.
Diese Teilnahme unterstreicht das Engagement von INBS, sich mit Investoren auseinanderzusetzen und seine innovativen Lösungen im Biotechnologiesektor vorzustellen.
- None.
- None.
NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a leader in non-invasive drug testing technology, today announced that its management team will participate in the Sidoti Small-Cap Virtual Conference being held on September 18-19, 2024.
Presentation Details
Date: Thursday, September 19, 2024
Time: 2:30 p.m. Eastern Time
Registration/Webcast Link: https://sidoti.zoom.us/webinar/register/WN_7jmynN8bTrqwS7q4Aupv7w
For more information about the conference, or to schedule a one-on-one meeting with the INBS management team, please contact your Sidoti representative or email KCSA Strategic Communications at INBS@ksca.com.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test for various indications, ranging from immunological conditions to communicable diseases. The Company’s current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.
For more information, visit: http://www.ibs.inc/
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
FAQ
When is Intelligent Bio Solutions (INBS) presenting at the Sidoti Small-Cap Virtual Conference?
How can I attend the INBS presentation at the Sidoti Small-Cap Virtual Conference?
What is the date range for the Sidoti Small-Cap Virtual Conference featuring INBS?
How can investors arrange meetings with INBS management during the Sidoti conference?
What is the main focus of Intelligent Bio Solutions (INBS) as mentioned in the press release?
